Pulmatrix, Inc. - Common Stock (PULM)

Pulmatrix just reported results for the second quarter of 2024.

Pulmatrix just reported results for the first quarter of 2024.

PULM stock results show that Pulmatrix beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.

  On Wednesday, 59 companies achieved new lows for the year.

  On Wednesday, 479 stocks made new 52-week lows.

  On Tuesday, 386 stocks made new 52-week lows.

As Pulmatrix executes a reverse stock split, shares of the tiny pharmaceutical company appear to be defying gravity.

  Friday's session saw 225 companies set new 52-week lows.

  On Tuesday, 99 stocks hit new 52-week lows.

  On Monday, 89 stocks made new 52-week lows.

Gainers Spero Therapeutics (NASDAQ:SPRO) shares moved upwards by 122.7% to $1.83 during Thursday's pre-market session. The market value of their outstanding shares is at $64.1 million.

Gainers Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million.

 

Gainers ECMOHO Limited (NASDAQ: MOHO) shares rose 47% to $0.2149 in pre-market trading.

Pulmatrix (NASDAQ: PULM) has dosed first subject in its Phase 1 trial evaluating PUR3100 for the treatment of acute migraine. PUR3100 is an orally-inhaled Dihydroergotamine (DHE) acute migraine therapy.

U.S. companies are cutting ties with Russia due to the war with Ukraine and we're going over which ones traders need to know about.

Good morning, investor! It's time to get into the thick of it with a dive into the biggest pre-market stock movers for Tuesday!

  During Friday's trading, 54 companies set new 52-week lows. Things to Consider About Today's 52-Week Lows: The largest company by market cap to hit a new 52-week...

Gainers Inspirato Incorporated (NASDAQ: ISPO) shares surged 50.5% to close at $54.90. Guardforce AI Co., Limited (NASDAQ: GFAI) jumped 45.4% to settle at $0.5979 on Friday. EF...

Gainers KAR Auction Services, Inc. (NYSE: KAR) shares climbed 39.2% to $19.05 after the company agreed to sell its ADESA U.S. physical auction business to Carvana for $2.2...

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Lilly's Co-developed Diabetes Drug Jardiance Gets Label Expansion To...

Gainers Cyren Ltd. (NASDAQ: CYRN) rose 54.6% to $7.48 in pre-market trading after gaining around 119% on Thursday. The company recently announced a $12 million private placement...